Early prediction of sustained viral responder and non-responder during interferon and ribavirin combination therapy in chronic hepatitis C

被引：3
|
作者：
Nakamura, H [1 ]
机构：
[1] Hyogo Med Univ, Dept Internal Med, Div Hepatobiliary & Pancreat Med, Nishinomiya, Hyogo 6638501, Japan
来源：
HEPATOLOGY RESEARCH | 2005年 / 33卷 / 04期
关键词：
D O I：
10.1016/j.hepres.2005.09.038
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：269 / 271
页数：3
相关论文
共 50 条
  • [1] EFFECTS OF CASCADE FILTRATION IN COMBINATION WITH INTERFERON AND RIBAVIRIN IN THE TREATMENT OF NON-RESPONDER CHRONIC HEPATITIS C PATIENTS
    Ramunni, A.
    Brescia, P.
    Burzo, M.
    Verno, L.
    Rendina, M.
    [J]. INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS, 2010, 33 (07): : 436 - 436
  • [2] Effect of interferon and ribavirin combined with amantadine in interferon and ribavirin non-responder patients with chronic hepatitis C (genotype 1)
    Oguz, Dilek
    Cicek, Bahattin
    Filik, Levent
    Odemis, Bulent
    Kilic, Mesut
    Altintas, Engin
    Zengin, Neslihan
    Altiparmak, Emin
    [J]. WORLD JOURNAL OF GASTROENTEROLOGY, 2005, 11 (04) : 580 - 583
  • [3] The combination therapy of ribavirin and pegylated interferon in non-responder, chronic HCV infection, hemodialysis patients
    Mousa, Dujanah
    Alsulaiman, Mohamad
    Alhawas, Fahad
    Alharbi, Wedad
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2007, 22 : 197 - 197
  • [4] Dynamics of hepatitis C virus NS5A quasispecies during interferon and ribavirin therapy in responder and non-responder patients with genotype 1b chronic hepatitis C
    Puig-Basagoiti, F
    Forns, X
    Furcic, I
    Ampurdanés, S
    Giménez-Barcons, M
    Franco, S
    Sanchez-Tapias, JM
    Saiz, JC
    [J]. JOURNAL OF GENERAL VIROLOGY, 2005, 86 : 1067 - 1075
  • [5] Effect of interferon and ribavirin combined with amantadine in interferon and ribavirin non-responder patients with chronic hepatitis C (genotype 1)
    Dilek Oguz
    Bahattin Cicek
    Levent Filik
    Bulent Odemis
    Mesut Kilic
    Engin Altintas
    Neslihan Zengin
    Emin Altiparmak
    [J]. World Journal of Gastroenterology, 2005, (04) : 580 - 583
  • [6] Daily use of ribavirin-interferon combination in earlier non-responder or relapser patients with chronic hepatitis C.
    Karasu, Z
    Gurakar, A
    Jazzar, A
    McMillon, G
    Hulagu, S
    Wright, H
    [J]. HEPATOLOGY, 1999, 30 (04) : 629A - 629A
  • [7] Retreatment of non-responder or relapser chronic hepatitis C patients with interferon plus ribavirin vs interferon alone
    Milella, M
    Santantonio, T
    Pietromatera, G
    Maselli, R
    Casalino, C
    Mariano, N
    Genchi, C
    Pastore, G
    [J]. ITALIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 1999, 31 (03): : 211 - 215
  • [8] Treatment of interferon non-responder patients with chronic hepatitis C in Asia
    Nishioka, M.
    [J]. CHRONIC HEPATITIS: METABOLIC, CHOLESTATIC, VIRAL AND AUTOIMMUNE, 2007, 157 : 110 - 118
  • [9] Dynamics of viral quasispecies during interferon therapy in non responder chronic hepatitis C patients
    Thelu, MA
    Baud, M
    Leroy, V
    Seigneurin, JM
    Zarski, JP
    [J]. JOURNAL OF CLINICAL VIROLOGY, 2001, 22 (01) : 125 - 131
  • [10] Retreatment of standard interferon/ribavirin non-responder patients with chronic hepatitis C with daily consensus interferon and ribavirin yields high sustained response rates.
    Kaiser, S
    Hass, HG
    Gregor, M
    [J]. HEPATOLOGY, 2003, 38 (04) : 276A - 276A
12345